AIVL For PWUD Wellbeing, Health & Human Rights✊️💜

@aivl.bsky.social

The PWUD Community-Controlled Peak Organisation that represents our network of Australian peer-based harm reduction & peer-led Drug User Organisations (DUOs) and supporting Asia-Pacific programs. #PeerPower www.aivl.org.au

The lack of public bathrooms in US cities harms unhoused people in particular and fuels public hostility, reports @tganeva.bsky.social. Experts discuss the drug war-related moral panic that's seen many bathrooms shut down, and ways to reduce risks today:

Lack of Public Bathrooms Makes Cities More Hostile - Filter

Back in February, a woman shared a tale of urban woe on social media. She wrote that her husband had ...

filtermag.org

A full room at our hybrid event at the EU Parliament in Brussels today. Thanks to the MEPs, our host, partners, and speakers who made this event a success. Now, we must build on this momentum to accelerate hepatitis elimination and strengthen liver cancer prevention across Europe.

BildBildBildBild

“Our goal is to establish dominance by offering better drugs and protection,” BJ, an upper-level supplier in his early 30s, told Filter. “It’s about building trust and ensuring that everyone benefits."

"We Are Doing It to Survive"—In Cape Town, the Drug Trade Feels Inevitable - Filter

Cape Town, South Africa, is a city renowned for its breathtaking landscapes and vibrant culture. Woven into the fabric of ...

filtermag.org

Medications for opioid use disorder (MOUD), like methadone & buprenorphine, are the most effective treatments for people struggling with addiction to opioids. They promote recovery and save lives by reducing cravings & withdrawal symptoms, while cutting overdose risk in half. But access is at risk👇

Bild

At 10 mg of naloxone per nasal spray, each dose of Rezenopy is the equivalent of two-and-a-half doses of Narcan. It’s the highest-dose naloxone nasal spray available—a distinction that comes with no proven benefits to people at risk of overdose filtermag.org/rezenopy-10-...

Rezenopy, the 10 Mg Naloxone Nasal Spray, Enters the OD Antidote Market - Filter

Two years after its approval by the Food and Drug Administration, opioid-overdose reversal product Rezenopy is about to make its ...

filtermag.org

“GLP-1 receptor agonists .. associated with ⬇️risk of a broad array of incident SUDs [Substance Use Disorders], suggesting potential preventive effects .. range of substances; GLP-1 receptor agonists .. also associated with ⬇️ risk of SUD related adverse clinical outcomes” www.bmj.com/content/392/...

Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study

Objectives To investigate whether initiation of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with both reduced risks of incident alcohol, cannabis, cocaine, nicotine, opioid, and ot...

bmj.com